Mickaël Lesurtel, MD, PhD; Pierre-Alain Clavien, MD, PhD
Our laboratory made the discovery of serotonin as a key mediator of liver regeneration and pathogenesis of cancer (Science 2008).
New Project: Temporary Portal Vein Occlusion and Liver Regeneration
The aims of this project were
- to assess the efficacy of temporary portal vein embolization (PVE) compared to permanent occlusion of the portal vein with embospheres or portal vein ligature (PVL) on hypertrophy of the non-embolized liver lobes;
- to assess histological and functional recovery of embolized liver lobes after temporary and permanent PVE.
